Targeted Genetics Corporation is a biotechnology company committed to the development and commercialization of innovative-targeted molecular therapies for the prevention and treatment of inflammatory arthritis and other acquired and inherited diseases with significant unmet medical need. The company has capabilities in the development and manufacturing of gene delivery technologies to advance a diverse product development pipeline. Its clinical development programs target potential therapies for inflammatory arthritis and a vaccine for HIV/AIDS, as well as pre-clinical programs for congestive heart failure, Huntington s disease and hyperlipidemia. Targeted Genetics is one of the leading manufacturers of adeno-associated virus vectors. It has developed a proprietary manufacturing process that utilizes the same technology used to produce monoclonal antibodies and therapeutic proteins. Targeted Genetics Corporation is headquartered in Seattle.